References
- 1. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, De La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends in microbiology. 2013;21(4):167-73.10.1016/j.tim.2012.12.00123332725
- 2. Aagaard KM. Mode of delivery and pondering potential sources of the neonatal microbiome. EBioMedicine 2020;51:102554.10.1016/j.ebiom.2019.11.015694064831901572
- 3. Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5(1):48.10.1186/s40168-017-0268-4541010228454555
- 4. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Scientific reports. 2016;6(1):1-3.10.1038/srep23129480238427001291
- 5. Wang M, Monaco MH, Donovan SM. Impact of early gut microbiota on immune and metabolic development and function. Semin Fetal Neonatal Med. 2016;21(6):380-87.10.1016/j.siny.2016.04.00427132110
- 6. Chen K, Yuan T. The role of microbiota in neonatal hyperbilirubinemia. Am J Transl Res. 2020;12(11):7459-74.
- 7. Fahmy K, Gray CH, Nicholson DC. The reduction of bile pigments by faecal and intestinal bacteria. Biochim Biophys Acta. 1972;264(1):85-97.10.1016/0304-4165(72)90119-54553810
- 8. Nobles CL, Green SI, Maresso AW. A product of heme catabolism modulates bacterial function and survival. PLoS Pathog. 2013;9(7):e1003507.10.1371/journal.ppat.1003507372356823935485
- 9. Watchko JF. Neonatal Hyperbilirubinemia and Kernicterus. In: Gleason CA, Devaskar SU, editors. Avery’s diseases of the newborn. 10th ed. Philadelphia, PA: Elsevier; 2018. p. 1492-517.
- 10. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, et al. Diversity of Bifidobacteria within the infant gut microbiota. PLoS One. 2012;7(5):e36957.10.1371/journal.pone.0036957335048922606315
- 11. Aires J, Thouverez M, Allano S, Butel MJ. Longitudinal analysis and genotyping of infant dominant bifidobacterial populations. Systematic and applied microbiology. 2011;34(7):536-41.10.1016/j.syapm.2011.02.00721680126
- 12. Deshmukh J, Deshmukh M, Patole S. Probiotics for the management of neonatal hyperbilirubinemia: a systematic review of randomized controlled trials. J Matern Fetal Neonatal Med. 2019;32(1):154-63.10.1080/14767058.2017.136952028823200
- 13. Chen Z, Zhang L, Zeng L, Yang X, Jiang L, Gui G. Probiotics supplementation therapy for pathological neonatal jaundice: a systematic review and meta-analysis. Front Pharmacol. 2017;8:432.10.3389/fphar.2017.00432549197128713275
- 14. Mutlu M, Aslan Y, Kader Ş, Acar FA. Preventive effects of probiotic supplementation on neonatal hyperbilirubinemia caused by isoimmunization. American journal of perinatology. 2020;37(11):1173-6.10.1055/s-0039-169269031242512
- 15. Tuzun F, Kumral A, Duman N, Ozkan H. Breast milk jaundice: effect of bacteria present in breast milk and infant feces. J Pediatr Gastroenterol Nutr. 2013;56(3):328-32.10.1097/MPG.0b013e31827a964b23132163
- 16. Zhou S, Wang Z, He F, Qiu H, Wang Y, Wang H, et al. Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis. J Nutr Biochem. 2019;63:54-61.10.1016/j.jnutbio.2018.09.01630342317
- 17. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008;152(6):801-6.10.1016/j.jpeds.2007.11.00518492520
- 18. Serce O, Gursoy T, Ovali F, Karatekin G. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial. Am J Perinatol. 2015;32(2):137-42.
- 19. Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, et.al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003;74(2):89-96.10.1016/S0378-3782(03)00090-2
- 20. Santosa I, Shoji H, Itoh S, Shimizu T. Roles of Probiotics in Reduction of Neonatal Jaundice in Term Newborns. Juntendo Medical Journal 2022;68(2):140-610.14789/jmj.JMJ21-0044-OA
- 21. Liu W, Liu H, Wang T, Tang X. Therapeutic effects of probiotics on neonatal jaundice. Pak J Med Sci. 2015;31(5):1172-75.10.12669/pjms.315.7921464127726649008
- 22. An H, Park S, Lee D, Kim J, Cha M, Lee S, et al. Anti obesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 2011;10:116.10.1186/1476-511X-10-116314684921745411
- 23. Zuo Z, Hai D, Wang Y, Wang C, Song L. Probiotics Protection Against Neonatal Hyperbilirubinemia. Chinese Journal of Medical Guide. 2015;11:1143-45.
- 24. Guarner F, Malagelada JR. Gut flora in healthy hand disease. Lancet 2003; 361(9356):512-19.10.1016/S0140-6736(03)12489-012583961
- 25. Ling WH, Korpela R, Mykkanen H, Salminen S, Hänninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124(1):18-23.10.1093/jn/124.1.188283290
- 26. Mutlu M, Irmak E, Aslan Y, Kader Ş. Effects of lactobacillus rhamnosus GG as a probiotic on neonatal hyperbilirubinemia. Turk J Pediatr. 2018;60(5):482-87.10.24953/turkjped.2018.05.00330968632
- 27. Makhoul G, Mardini J, Ojaimi MA, AbiFares G, Hanna P, Alameddine A, et al. Effect of Probiotic “L.Reuteri” Association on the Reduction of Serum Bilirubin in Neonatal Jaundice. ESJ. 2018;14(12):384.10.19044/esj.2018.v14n12p384
- 28. Teran CG, Grandy G, Walker-Pizarro N. The role of probiotics in preventing neonatal hyperbilirubinemia. J Clin Neonatol. 2021;10(3):178-81.10.4103/jcn.jcn_202_20
- 29. Nouri Shadkam M, Jalalizadeh F, Nasiriani K. Effects of probiotic lactobacillus reuteri (DSM 17938) on the incidence of necrotizing enterocolitis in very low birth weight premature infants. IJN. 2015;6(4):15-20.